Section V. Assessment for Renovascular Hypertension 2015 Canadian Hypertension Education Program Recommendations.

Slides:



Advertisements
Similar presentations
Kieran McGlade Nov 2001 Department of General Practice QUB Hypertension.
Advertisements

ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial The telmisartan trial in cardiovascular protection Sponsored by Boehringer.
DIABETES AND THE KIDNEYS
Etiology Primary hypertension 95% of all cases Secondary hypertension – 5% of all cases – Chronic renal disease – most common White coat hypertension –
Mugendi AG, BPharm, MPharm (Clin Pharm). Comparison of the effects of losartan and enalapril on renal function in adults with chronic kidney disease at.
Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP
The ONTARGET Trial Reference The ONTARGET investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:15.
2011 Canadian Hypertension Education Program Recommendations
2007 Part 1: Recommendations for Hypertension Diagnosis Assessment and Follow up January, 2007.
HYPERTENSION “DILEMMAS IN TREATMENT” Dr. N. Dean MBBS FRCP (UK)
Early Detection and Prevention of Renal Failure Linda Fried, MD, MPH.
MANAGEMENT HTN IN PREGNANCY. DEFINITIONS The definition of gestational hypertension is somewhat controversial. Some clinicians therefore recommend close.
Implementing NICE guidance
Office Evaluation of Hypertension December 2, 2008.
TITLE EFFICACY OF UNENHANCED MAGNETIC RESONANCE RENAL ANGIOGRAPHY IN PATIENTS WITH ACUTE /CHRONIC KIDNEY DISEASE WITH CLINICAL SUSPICION OF RENOVASCULAR.
Section 6: Management in primary care Particular emphasis on nurse practitioner’s role.
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
Hypertension NICE CG127 August Hypertension is not a disease it is a risk factor for cardiovasuclar disease (CVD)-it is a modifiable risk factor.
Radka Adlová Arterial hypertension and preventive cardiology.
Although in more than 90% of patients with high blood pressure no underlying causes could be identified, up to 10% of hypertensives have a secondary.
Safety update Anthony Ormerod. Why is safety important? Clinical trial / European directive MHRA / governance Severe disease Patients have large burden.
Section IV. Routine and Optional Laboratory Tests for the Investigation of Patients with Hypertension 2015 Canadian Hypertension Education Program Recommendations.
Part 1: Recommendations for Hypertension Diagnosis, Assessment, and Follow-up 2015 Canadian Hypertension Education Program Recommendations.
Renovascular hypertension Dr Saad Al Shohaib KAUH.
CHRONIC KIDNEY DISEASE
Dr.AZDAKI (cardiologist).   Initial monotherapy is successful in many patients with mild primary hypertension (formerly called "essential" hypertension).
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Serum Creatinine Is an Inadequate Screening Test.
Date of download: 5/28/2016 From: New Fibrate Use and Acute Renal Outcomes in Elderly Adults: A Population-Based Study Ann Intern Med. 2012;156(8):
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Risk of Mortality and End-Stage Renal Disease.
Relationship between coronary and renal artery disease and associated risk factors in hypertensive and diabetic patients undergoing coronary angiography.
KIDNEY & HYPERTENTION 1 Dr. Ruba Nashawati. Kidney Hypertension 2.
Internal Medicine Workshop Series Laos September /October 2009.
Date of download: 6/23/2016 From: Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive.
CLINICAL ASPECTS OF HYPERTENSION APPROACH TO THE PATIENT WHEN HYPERTENSION IS SUSPECTED, BP SHOULD BE MEASURED AT LEAST TWICE DURING TWO SEPARATE EXAMINATIONS.
Resistant Hypertension - Primary Aldosteronism - 내분비 대사 내과 R3 송 란.
Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Angiotensin-Converting Enzyme Inhibitor–Associated.
Hypertension Dr.Emamzadegan Pediatric Cardiologist.
Renovascular Hypertension
Copyright © 2015 by the American Osteopathic Association.
Darshika Chhabra, MD, MPH
TUCOM Internal Medicine 4th class
Hypertension JNC VIII Guidelines.
Vitamin D levels and patient outcome in chronic kidney disease
FIGURE 1 Flow chart of the study population
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Thinking Beyond New Clinical Guidelines: Update in Hypertension
Volume 93, Issue 4, Pages (April 2018)
Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus  George L. Bakris, MD  Mayo Clinic.
Shipra Arya, MD, SM, Dawn M. Coleman, MD, Nicholas H
Hypertension evaluation
Volume 53, Issue 4, Pages (April 1998)
Category Hypertension Normal < 130/< 85 Recheck in 2 years. High Normal 130–139/ 85–89 Recheck in 1 year Hypertension Stage 1 (mild) 140–159/90–99.
Nat. Rev. Cardiol. doi: /nrcardio
Audit-based education: a potentially effective program for improving guideline achievement in CKD patients  Moniek C.M. de Goeij, Joris I. Rotmans  Kidney.
Volume 63, Issue 3, Pages (March 2003)
Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016  Murray Epstein, MD, Daniel A. Duprez,
Steven J. Rosansky, Richard J. Glassock  Kidney International 
Hypertension After Kidney Transplant
Volume 69, Issue 12, Pages (June 2006)
Treatment Algorithm for Guideline-Directed Medical Therapy Including Novel Therapies (2,9) Green diamonds indicate Class I guideline recommendations, while.
Vitamin D levels and patient outcome in chronic kidney disease
Internal Medicine Workshop Series Laos September /October 2009
Volume 81, Issue 7, Pages (April 2012)
Volume 73, Issue 5, Pages (March 2008)
Volume 80, Issue 10, Pages (November 2011)
Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or angiotensin receptor blocker (ARB) is.
Combination angiotensin-converting enzyme inhibitor (ACEI)/angiotensin II receptor blocker (ARB) reduced risk for renal end point versus ACEI or ARB. Effect.
Proteinuria and hypertension with tyrosine kinase inhibitors
Percentage of patients found with a kidney function too low for recommended use of the drug using estimated glomerular filtration rate compared with creatinine.
Hypertension & Exercise 杨晓冬 级临床医学(八年制)
Presentation transcript:

Section V. Assessment for Renovascular Hypertension 2015 Canadian Hypertension Education Program Recommendations

2015 V. Assessment for Renovascular Hypertension Patients presenting with two or more of the following clinical clues listed below suggesting renovascular hypertension should be investigated. I.Sudden onset or worsening of hypertension and age >55 or <30 years II.The presence of an abdominal bruit III.Hypertension resistant to 3 or more drugs IV.A rise in creatinine of 30% or more associated with use of an angiotensin converting enzyme inhibitor or angiotensin II receptor blocker V.Other atherosclerotic vascular disease, particularly in patients who smoke or have dyslipidemia VI.Recurrent pulmonary edema associated with hypertensive surges

2015 V. Assessment for Renovascular Hypertension The following tests are recommended, when available, to screen for renal vascular disease: captopril-enhanced radioisotope renal scan* doppler sonography magnetic resonance angiography CT-angiography (for those with normal renal function) * captopril-enhanced radioisotope renal scan is not recommended for those with glomerular filtration rates <60 mL/min)